|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.39 USD | +0.26% |
|
+0.52% | +10.96% |
| 12/01 | UBS Adjusts Price Target on FMC to $15 From $17, Maintains Neutral Rating | MT |
| 08/01 | BofA Securities Adjusts FMC Price Target to $17 From $18, Maintains Neutral Rating | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.78 | 6.94 | 7.08 | 3.68 | 3.37 | |||||
Return on Total Capital | 10.93 | 11.25 | 11.63 | 5.53 | 4.8 | |||||
Return On Equity % | 20.88 | 26.58 | 25.63 | 36.24 | 9.02 | |||||
Return on Common Equity | 21.06 | 26.79 | 25.59 | 36.39 | 9.03 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 44.2 | 43.04 | 40.1 | 40.81 | 38.83 | |||||
SG&A Margin | 14.57 | 14.15 | 13.36 | 16.37 | 15.18 | |||||
EBITDA Margin % | 26.94 | 26.25 | 24.25 | 19.25 | 19.11 | |||||
EBITA Margin % | 24.76 | 24.1 | 22.37 | 16.57 | 16.5 | |||||
EBIT Margin % | 23.43 | 22.86 | 21.33 | 15.14 | 14.96 | |||||
Income From Continuing Operations Margin % | 12.47 | 15.9 | 14.45 | 31.64 | 9.5 | |||||
Net Income Margin % | 11.88 | 14.6 | 12.69 | 29.45 | 8.03 | |||||
Net Avail. For Common Margin % | 12.46 | 15.91 | 14.34 | 31.59 | 9.46 | |||||
Normalized Net Income Margin | 12.63 | 12.71 | 11.61 | 5.12 | 5.87 | |||||
Levered Free Cash Flow Margin | 10.75 | 13.41 | 10.28 | -9.53 | 19.81 | |||||
Unlevered Free Cash Flow Margin | 12.79 | 15.03 | 11.92 | -6.23 | 23.28 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.46 | 0.49 | 0.53 | 0.39 | 0.36 | |||||
Fixed Assets Turnover | 5.04 | 5.39 | 6.03 | 4.51 | 4.3 | |||||
Receivables Turnover (Average Receivables) | 2.04 | 2.05 | 2.13 | 1.61 | 1.51 | |||||
Inventory Turnover (Average Inventory) | 2.45 | 2.3 | 2.19 | 1.57 | 1.78 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.55 | 1.4 | 1.43 | 1.52 | 1.64 | |||||
Quick Ratio | 1.1 | 0.95 | 0.96 | 0.96 | 1.17 | |||||
Operating Cash Flow to Current Liabilities | 0.23 | 0.23 | 0.15 | -0.11 | 0.22 | |||||
Days Sales Outstanding (Average Receivables) | 179.82 | 177.75 | 171.58 | 226.75 | 241.63 | |||||
Days Outstanding Inventory (Average Inventory) | 149.26 | 158.86 | 166.64 | 232 | 206.18 | |||||
Average Days Payable Outstanding | 126.64 | 119.33 | 120.84 | 124.03 | 120.95 | |||||
Cash Conversion Cycle (Average Days) | 202.45 | 217.28 | 217.38 | 334.72 | 326.86 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 115.42 | 109.31 | 100.7 | 92.6 | 77.54 | |||||
Total Debt / Total Capital | 53.58 | 52.22 | 50.17 | 48.08 | 43.67 | |||||
LT Debt/Equity | 103.23 | 94.1 | 84.15 | 70.98 | 69.51 | |||||
Long-Term Debt / Total Capital | 47.92 | 44.96 | 41.93 | 36.85 | 39.15 | |||||
Total Liabilities / Total Assets | 70.7 | 71.16 | 69.56 | 62.83 | 61.31 | |||||
EBIT / Interest Expense | 7.19 | 8.8 | 8.15 | 2.86 | 2.69 | |||||
EBITDA / Interest Expense | 8.56 | 10.4 | 9.53 | 3.84 | 3.65 | |||||
(EBITDA - Capex) / Interest Expense | 7.68 | 9.63 | 8.59 | 3.27 | 3.36 | |||||
Total Debt / EBITDA | 2.66 | 2.45 | 2.37 | 4.51 | 4.06 | |||||
Net Debt / EBITDA | 2.22 | 2.07 | 1.96 | 4.18 | 3.65 | |||||
Total Debt / (EBITDA - Capex) | 2.96 | 2.64 | 2.63 | 5.29 | 4.41 | |||||
Net Debt / (EBITDA - Capex) | 2.48 | 2.23 | 2.18 | 4.9 | 3.96 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 0.7 | 8.68 | 15.01 | -22.67 | -5.36 | |||||
Gross Profit, 1 Yr. Growth % | -1.52 | 5.83 | 7.66 | -21.31 | -9.95 | |||||
EBITDA, 1 Yr. Growth % | 2.45 | 5.9 | 7.08 | -38.62 | -6.03 | |||||
EBITA, 1 Yr. Growth % | 1.47 | 5.78 | 7.66 | -42.72 | -5.77 | |||||
EBIT, 1 Yr. Growth % | 1.62 | 6.03 | 8.27 | -45.11 | -6.49 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 6.51 | 38.57 | 4.15 | 69.25 | -71.58 | |||||
Net Income, 1 Yr. Growth % | 15.52 | 33.54 | -0.42 | 79.43 | -74.19 | |||||
Normalized Net Income, 1 Yr. Growth % | 3.36 | 9.41 | 6.08 | -65.89 | 8.41 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 8.29 | 40.32 | 5.21 | 71.94 | -71.62 | |||||
Accounts Receivable, 1 Yr. Growth % | 4.44 | 10.87 | 11.14 | -5.86 | 7.4 | |||||
Inventory, 1 Yr. Growth % | 7.73 | 28.3 | 8.52 | 4.42 | -30.33 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -0.4 | 3.61 | 2.23 | 4.2 | -5.34 | |||||
Total Assets, 1 Yr. Growth % | 3.18 | 3.88 | 4.67 | 6.76 | -2.29 | |||||
Tangible Book Value, 1 Yr. Growth % | -23.25 | -15.02 | -15.15 | -126.85 | 121.8 | |||||
Common Equity, 1 Yr. Growth % | 16.96 | 2.39 | 8.12 | 30.58 | 1.74 | |||||
Cash From Operations, 1 Yr. Growth % | 32.61 | 26.6 | -28.98 | -166.35 | -273.68 | |||||
Capital Expenditures, 1 Yr. Growth % | 41.43 | -24.62 | 42.16 | -5.9 | -49.29 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -31.66 | 35.56 | 0.88 | -171.69 | -296.72 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -28.53 | 27.77 | 2.7 | -140.41 | -453.84 | |||||
Dividend Per Share, 1 Yr. Growth % | 9.76 | 9.44 | 10.15 | 6.91 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 4.08 | 4.62 | 11.8 | -5.7 | -14.45 | |||||
Gross Profit, 2 Yr. CAGR % | 2.6 | 2.09 | 6.62 | -7.96 | -15.82 | |||||
EBITDA, 2 Yr. CAGR % | 7.04 | 4.16 | 6.3 | -16.78 | -24.05 | |||||
EBITA, 2 Yr. CAGR % | 6.12 | 3.6 | 6.5 | -19.2 | -26.53 | |||||
EBIT, 2 Yr. CAGR % | 6.52 | 3.8 | 6.92 | -20.55 | -28.36 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 3.77 | 21.49 | 20.27 | 32.77 | -30.65 | |||||
Net Income, 2 Yr. CAGR % | 4.8 | 24.21 | 15.47 | 33.67 | -31.95 | |||||
Normalized Net Income, 2 Yr. CAGR % | 7.57 | 6.34 | 7.49 | -37.76 | -39.19 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 6.94 | 23.27 | 21.66 | 34.5 | -30.14 | |||||
Accounts Receivable, 2 Yr. CAGR % | 4.26 | 7.61 | 11 | 2.29 | 0.55 | |||||
Inventory, 2 Yr. CAGR % | 3.36 | 17.57 | 22.78 | 6.45 | -14.7 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 10.19 | 1.59 | 2.92 | 3.21 | -0.69 | |||||
Total Assets, 2 Yr. CAGR % | 1.06 | 3.53 | 4.72 | 5.71 | 2.13 | |||||
Tangible Book Value, 2 Yr. CAGR % | 7.71 | -19.24 | -18.72 | -52.27 | -22.83 | |||||
Common Equity, 2 Yr. CAGR % | -2.59 | 9.43 | 6.79 | 18.82 | 15.26 | |||||
Cash From Operations, 2 Yr. CAGR % | 32.61 | 29.57 | -5.18 | -31.36 | 7.35 | |||||
Capital Expenditures, 2 Yr. CAGR % | 26.49 | 3.25 | 3.52 | 15.66 | -30.92 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 7.93 | -3.75 | 6.04 | -11.78 | 18.76 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 7.62 | -4.44 | 5.18 | -33.48 | 19.58 | |||||
Dividend Per Share, 2 Yr. CAGR % | 41.42 | 9.6 | 9.8 | 8.52 | 3.4 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 22.4 | 5.59 | 7.97 | -1.13 | -5.59 | |||||
Gross Profit, 3 Yr. CAGR % | 28.28 | 3.67 | 3.75 | -3.64 | -8.63 | |||||
EBITDA, 3 Yr. CAGR % | 37.6 | 6.66 | 4.85 | -11.48 | -13.34 | |||||
EBITA, 3 Yr. CAGR % | 41.14 | 6.01 | 4.64 | -13.39 | -14.95 | |||||
EBIT, 3 Yr. CAGR % | 41.72 | 6.36 | 4.95 | -14.39 | -16.12 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 63.23 | 14.27 | 15.56 | 34.78 | -20.58 | |||||
Net Income, 3 Yr. CAGR % | 0.97 | 13.62 | 15.55 | 33.74 | -22.74 | |||||
Normalized Net Income, 3 Yr. CAGR % | 46.4 | 8.18 | 5.9 | -26.68 | -25.11 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 63.77 | 17.08 | 17 | 36.53 | -19.92 | |||||
Accounts Receivable, 3 Yr. CAGR % | 4.48 | 6.42 | 8.77 | 5.07 | 3.96 | |||||
Inventory, 3 Yr. CAGR % | 3.35 | 11.08 | 17.54 | 16.33 | -7.57 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -3.58 | 7.95 | 1.8 | 3.34 | 0.28 | |||||
Total Assets, 3 Yr. CAGR % | 3.43 | 1.99 | 4.21 | 5.4 | 2.97 | |||||
Tangible Book Value, 3 Yr. CAGR % | 3.15 | -0.47 | -20.26 | -43.81 | -20.35 | |||||
Common Equity, 3 Yr. CAGR % | 3.37 | -0.96 | 10.08 | 14.2 | 12.83 | |||||
Cash From Operations, 3 Yr. CAGR % | 24.52 | 30.57 | 6.04 | -15.82 | -6.47 | |||||
Capital Expenditures, 3 Yr. CAGR % | 51.36 | 6.44 | 14.86 | 0.28 | -12.14 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 11.75 | 16.45 | -6.52 | -6.93 | 15.26 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 13.35 | 13.96 | -5.92 | -23.54 | 16.12 | |||||
Dividend Per Share, 3 Yr. CAGR % | 39.71 | 29.84 | 9.78 | 8.83 | 5.6 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 13.26 | 14.72 | 18.05 | 0.92 | -1.63 | |||||
Gross Profit, 5 Yr. CAGR % | 19.05 | 18.45 | 19.07 | -1.25 | -4.57 | |||||
EBITDA, 5 Yr. CAGR % | 25.56 | 22.22 | 24 | -4.58 | -7.84 | |||||
EBITA, 5 Yr. CAGR % | 27.48 | 24.37 | 25.99 | -6.14 | -9.17 | |||||
EBIT, 5 Yr. CAGR % | 27.41 | 24.54 | 26.49 | -6.66 | -9.91 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 22.18 | 43.75 | 44.51 | 21.43 | -5.79 | |||||
Net Income, 5 Yr. CAGR % | 2.43 | 28.64 | 6.57 | 21.35 | -6.5 | |||||
Normalized Net Income, 5 Yr. CAGR % | 30.5 | 26.37 | 29.23 | -14.63 | -15.18 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 21.73 | 45.55 | 45.39 | 23.8 | -4.81 | |||||
Accounts Receivable, 5 Yr. CAGR % | 4.71 | 8.83 | 7.04 | 4.75 | 5.41 | |||||
Inventory, 5 Yr. CAGR % | 6.49 | 24.03 | 10.72 | 10.96 | 3.39 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -1.99 | 12.09 | -1.03 | 6.03 | 0.8 | |||||
Total Assets, 5 Yr. CAGR % | 10 | 11.5 | 3.94 | 3.64 | 3.37 | |||||
Tangible Book Value, 5 Yr. CAGR % | 42.96 | 9.16 | -6.22 | -27.11 | -21.3 | |||||
Common Equity, 5 Yr. CAGR % | 9.68 | 9.15 | 4.72 | 7.16 | 12.12 | |||||
Cash From Operations, 5 Yr. CAGR % | 12.59 | 10.5 | 11.66 | 0.96 | 6.56 | |||||
Capital Expenditures, 5 Yr. CAGR % | 19.99 | 1.88 | 30.02 | 10.04 | -6.28 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 41.02 | 14.6 | 10.78 | -0.03 | 2.87 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 35.84 | 14.71 | 11.15 | -11.42 | 3.55 | |||||
Dividend Per Share, 5 Yr. CAGR % | 22.22 | 24.45 | 26.88 | 20.85 | 7.18 |
- Stock Market
- Equities
- FMC Stock
- Financials FMC Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















